# FDA 483 - Apex Display Group, LLC - October 31, 2025

Source: https://www.globalkeysolutions.net/records/483/apex-display-group-llc/61a18d1c-bbb3-4b9d-a365-26f7013444aa

> FDA 483 for Apex Display Group, LLC on October 31, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Apex Display Group, LLC
- Inspection Date: 2025-10-31
- Product Type: drugs
- Office Name: Philadelphia District Office
- Summary: An FDA inspection of Apex Display Group, LLC, an OTC packer in Lansdale, PA, revealed significant deficiencies across its quality system. The firm lacked a functional quality control unit, failed to establish adequate laboratory controls for incoming materials, and maintained incomplete batch production and control records. These critical issues indicate a severe lack of adherence to cGMP conditions, raising concerns about the safety, effectiveness, and quality of the drug products packaged.

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/kellia-n-hicks/44104c4a-70c1-47fc-9a77-c09c41bacc2b)

Company: https://www.globalkeysolutions.net/companies/apex-display-group-llc/d07477de-0209-431c-bc0a-7708e79f904b

Office: https://www.globalkeysolutions.net/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8